
The headline: more sales, bigger loss
Live Nation Entertainment posted first-quarter results after Tuesday’s close, and the numbers came with a little rock-concert chaos. Revenue rose to $3.793 billion from $3.382 billion a year ago, but the company also reported a loss of $1.85 per share, compared with a 32-cent loss in the same quarter last year.
That’s not exactly the kind of earnings beat that sends investors crowd-surfing. On one hand, higher sales suggest the live-events machine is still pulling in fans, fees, and all the other deliciously annoying line items that keep this business humming. On the other hand, the wider loss reminds you that scaling a giant entertainment empire is expensive — and sometimes the margin math refuses to cooperate.
Why investors should care
For Live Nation, the big question is always the same: can it keep the stadiums full without turning every extra dollar of revenue into a dollar of headache? Revenue growth is nice, but Wall Street tends to get twitchy when profitability doesn’t keep up.
The stock closed down 0.2% Tuesday at $157.26, which is basically the market shrugging and saying, “Show me the encore.” Investors will be watching whether ticket demand, pricing power, and cost control can all play nicely together in the next quarter.
The rest of CNBC’s parade
The segment also tossed out a few other names:
- TransDigm said it had a strong quarter, with earnings and sales both topping expectations.
- UnitedHealth got a fresh Overweight call from J.P. Morgan, along with a higher price target.
- Interactive Brokers hit an all-time high and reported 4.241 million daily average revenue trades on May 1.
Big picture: Live Nation’s quarter says the concert business still has plenty of life — but for investors, revenue growth alone isn’t the whole show anymore.
